Netflix’s advertising business is still small next to the rest of the company, but the numbers in its latest shareholder ...

Omnicom is set to merge media agencies Mediahub and Hearts & Science in the latest shake-up following its acquisition of ...

Biotech acquisitions surged to $216 billion; Latest on the cyclospora outbreak; Unpacking Anthropic's 100-day sprint into ...

In the latest pair of Untitled Letters, the FDA took issue with a Viatris TV ad and Sanofi’s promotional emails.

AI accelerates drug development; FDA continues to point finger at Taylor Farms for cyclospora outbreak; RI fugitive found at ...

If the FDA’s proposed rule to remove adequate provision is finalized, the traditional 30- or 60-second pharma TV ad might ...

The Publicis chairman and chief executive spoke to Campaign following the group's latest results, in which it revealed the ...

As the Trump administration’s January deadline looms for states to enforce new Medicaid work requirements, some state ...

Merck’s cholesterol pill was the first of its kind approved by the FDA; Prediction market exchange Klashi will allow betting ...

Medicare Advantage insurers face scrutiny over use of AI to block rehabilitative care; Trump administration did not move ...

The public comment period closed this week for a proposed regulation that could fundamentally rewrite American biomedical research rules. If the response is any indication, the rule has few fans in ...

While consumer research can still help brands with isolated needs, marketers are increasingly expecting this budget to back ...